Oriano Marin Selected Research

Cerebellar Ataxia (Dysmetria)

1/2018	A V1143F mutation in the neuronal-enriched isoform 2 of the PMCA pump is linked with ataxia.
1/2017	The ataxia related G1107D mutation of the plasma membrane Ca2+ ATPase isoform 3 affects its interplay with calmodulin and the autoinhibition process.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Oriano Marin Research Topics

Disease

11	Neoplasms (Cancer) 01/2023 - 09/2003
3	Cystic Fibrosis (Mucoviscidosis) 12/2013 - 07/2008
3	T-Cell Leukemia (Leukemia, T Cell) 05/2010 - 09/2002
2	Infections 05/2021 - 10/2016
2	Parkinson Disease (Parkinson's Disease) 01/2021 - 02/2012
2	Mucopolysaccharidosis II (Hunter Syndrome) 04/2019 - 11/2005
2	Cerebellar Ataxia (Dysmetria) 01/2018 - 01/2017
2	Ataxia (Dyssynergia) 01/2018 - 01/2017
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2016 - 07/2005
2	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 09/2011 - 10/2007
2	Genetic Translocation (Chromosomal Translocation) 09/2011 - 10/2007
2	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 10/2007 - 09/2003
1	Pseudomonas Infections 08/2023
1	Fibrosis (Cirrhosis) 01/2023
1	Disease Progression 01/2023
1	Starvation 09/2022
1	Heart Diseases (Heart Disease) 01/2022
1	Carcinogenesis 01/2021
1	Osteosarcoma (Osteogenic Sarcoma) 01/2021
1	Colonic Neoplasms (Colon Cancer) 01/2020
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2020
1	Deafness (Deaf Mutism) 01/2018
1	Charcot-Marie-Tooth Disease (Peroneal Muscular Atrophy) 01/2018
1	Hearing Loss (Hearing Impairment) 01/2018
1	1 X-linked Charcot-Marie-Tooth disease 01/2018
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2018
1	Carcinoma (Carcinomatosis) 01/2017
1	Mucopolysaccharidosis I (Hurler Syndrome) 01/2016
1	Central Nervous System Diseases (CNS Diseases) 01/2016
1	Hyperglycemia 09/2015
1	Diabetes Complications 09/2015
1	Esophageal Neoplasms (Esophageal Cancer) 01/2015
1	Adenocarcinoma 01/2015
1	Synucleinopathies 02/2012
1	Colorectal Neoplasms (Colorectal Cancer) 09/2011
1	Virus Diseases (Viral Diseases) 09/2011
1	Breast Neoplasms (Breast Cancer) 08/2009
1	Emery-Dreifuss Muscular Dystrophy (Scapuloperoneal Muscular Dystrophy) 11/2008
1	Neurodegenerative Diseases (Neurodegenerative Disease) 09/2006
1	Epilepsy (Aura) 08/2005
1	Obesity 07/2005

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 01/2021 - 09/2002
5	Peptides (Polypeptides)IBA 05/2021 - 08/2005
5	Phosphotransferases (Kinase)IBA 09/2011 - 06/2005
4	EnzymesIBA 04/2019 - 07/2002
3	Anaplastic Lymphoma KinaseIBA 09/2011 - 06/2005
2	SynucleinsIBA 01/2021 - 02/2012
2	GlycosaminoglycansIBA 04/2019 - 11/2005
2	Protein Isoforms (Isoforms)IBA 01/2018 - 01/2017
2	Adenosine Triphosphate (ATP)IBA 01/2018 - 10/2015
2	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 12/2013 - 07/2008
2	Protein Kinases (Protein Kinase)IBA 10/2011 - 08/2005
2	beta CateninIBA 10/2007 - 09/2003
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 10/2007 - 05/2005
1	Insecta cecropin B proteinIBA 08/2023
1	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 01/2023
1	Mechanistic Target of Rapamycin Complex 1IBA 09/2022
1	Nerve Growth Factor (NGF)IBA 01/2022
1	Protein AggregatesIBA 01/2021
1	2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA 01/2020
1	HexokinaseIBA 01/2020
1	Iduronic Acid (Iduronate)IBA 04/2019
1	Gap Junction beta-1 ProteinIBA 01/2018
1	Cadherins (E-Cadherin)IBA 01/2018
1	Calcium-Transporting ATPases (Ca2+ ATPase)IBA 01/2017
1	Monoclonal AntibodiesIBA 01/2017
1	AntigensIBA 01/2017
1	Calmodulin (Calcium-Dependent Activator Protein)IBA 01/2017
1	Therapeutic UsesIBA 10/2016
1	Cyclic PeptidesIBA 10/2015
1	Cell-Penetrating PeptidesIBA 10/2015
1	Complement System Proteins (Complement)IBA 09/2015
1	Glucagon-Like Peptide 1 (GLP 1)IBA 09/2015
1	Biomarkers (Surrogate Marker)IBA 09/2015
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 09/2011
1	Oncogene Proteins (Oncogene Protein)IBA 09/2011
1	NucleophosminIBA 09/2011
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 05/2010
1	Viroporin ProteinsIBA 05/2010
1	HoloenzymesIBA 01/2010
1	Hormones (Hormone)IBA 08/2009
1	Peptide Elongation Factor 1 (EF-1)IBA 08/2009
1	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2009
1	AcidsIBA 07/2009
1	Lamin Type A (Lamin A)IBA 11/2008
1	NucleotidesIBA 07/2008
1	Casein Kinase II (Casein Kinase 2)IBA 07/2008
1	RNA (Ribonucleic Acid)IBA 10/2007
1	DNA-Binding Proteins (DNA Binding Protein)IBA 10/2007
1	Intrinsically Disordered ProteinsIBA 09/2006
1	alpha-SynucleinIBA 09/2006
1	Heparitin Sulfate (Heparan Sulfate)IBA 11/2005
1	kemptideIBA 08/2005
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 08/2005
1	Messenger RNA (mRNA)IBA 07/2005

Therapy/Procedure

1	Sympathectomy (Sympathectomies) 01/2022
1	Enzyme Replacement Therapy 01/2016
1	Lasers (Laser) 01/2015
1	Therapeutics 09/2011
1	Radiotherapy 08/2009